TrialTargeted oncology2019

Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.